Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study)

BMC Pregnancy and Childbirth

Volumn 10, Issue , 2010, Pages

  Delahaije, Denise H J ^a   van Kuijk, Sander M J ^a,b   Dirksen, Carmen D ^a   Sep, Simone J S ^a,b   Peeters, Louis L ^a   Spaanderman, Marc E ^c   Bruinse, Hein W ^d   de Wit Zuurendonk, Laura D ^e   van der Post, Joris A M ^f   Duvekot, Johannes J ^g   van Eyck, Jim ^h   van Pampus, Mariëlle G ⁱ   van der Hoeven, Mark A B H M ^a   Smits, Luc J ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e MÁXIMA MEDICAL CENTER   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h ISALA HOSPITAL   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOGLIN; FIBRONECTIN; HEMOGLOBIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HELLP SYNDROME; HEMOGLOBIN BLOOD LEVEL; HUMAN; MATERNAL CARE; MICROALBUMINURIA; NETHERLANDS; PREECLAMPSIA; PREGNANCY; PRENATAL CARE; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RECURRENT DISEASE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; UNIVERSITY HOSPITAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; HIGH RISK PREGNANCY; METHODOLOGY; MONITORING; MORTALITY; PATIENT CARE PLANNING; PRACTICE GUIDELINE; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; RISK; RISK ASSESSMENT; STATISTICAL MODEL;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; GRAVIDITY; HELLP SYNDROME; HUMANS; MODELS, ECONOMIC; MONITORING, PHYSIOLOGIC; PATIENT CARE PLANNING; PRACTICE GUIDELINES AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, HIGH-RISK; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; RECURRENCE; RISK; RISK ASSESSMENT;

EID: 77957659363     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-10-60     Document Type: Article

References (31)

1. Davison JM, Homuth V, Jeyabalan A, Conrad KP, Karumanchi A, Quaggin S, Dechend R, Luft FC. New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol 2004, 15:2440-2448. 10.1097/01.ASN.0000135975.90889.60, 15339993.
2. Barden A. Pre-eclampsia: contribution of maternal constitutional factors and the consequences for cardiovascular health. Clin Exp Pharmacol Physiol 2006, 33:826-830. 10.1111/j.1440-1681.2006.04448.x, 16922815.
3. Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, Roberts TE, Mol BW, van der Post JA, Leeflang MM, Barton PM, Hyde CJ, Gupta JK, Khan KS. Methods of prediction and prevention of pre- eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2008, 12:1-270.
4. Osmond C, Kajantie E, Forsén TJ, Eriksson JG, Barker DJ. Infant growth and stroke in adult life: the Helsinke Birth Cohort Study. Stroke 2007, 38:264-270. 10.1161/01.STR.0000254471.72186.03, 17218608.
5. Eriksson JG, Forsén T, Tuomilheto J, Osmond C, Barker DJ. Early growth and coronary heart disease in later life: longitudinal study. BMJ 2001, 322:949-953. 10.1136/bmj.322.7292.949, 31033, 11312225.
6. Barker DJ, Martyn CN, Osmond C, Hales CN, Fall CH. Growth in utero and serum cholesterol concentrations in adult life. BMJ 1993, 307:1524-1527. 10.1136/bmj.307.6918.1524, 1679540, 8274921.
7. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
8. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: Clinical issues and management. A Review. BMC Pregnancy Childbirth 2009, 9:8. 10.1186/1471-2393-9-8, 2654858, 19245695.
9. Schutte JM, Schuitemaker NWE, van Roosmalen J, Steegers EAP. Substandard care in maternal mortality due to hypertensive disease in pregnancy in the Netherlands. BJOG 2008, 115:732-736. 10.1111/j.1471-0528.2008.01702.x, 18410657.
10. NVOG Richtlijn 6 - Hypertensieve aandoeningen in de zwangerschap, versie 2.0; mei 2005. 2005, NVOG., http://www.nvog-documenten.nl/richtlijn/doc/download.php?id=519
11. Society of Obstetricians and Gynaecologists of Canada Diagnosis, evaluation and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008, 30(Suppl 1). Society of Obstetricians and Gynaecologists of Canada.
12. Société française d'anesthésie et de réanimation (Sfar), Collège national des gynécologues et obstétriciens français (CNGOF), Société française de médecine périnatale (SFMP) and Société française de néonatalogie (SFNN) Multidisciplinary management of severe pre-eclampsia. Experts' guidelines 2008. Ann Fr Anesth Reanim 2009, 28:275-281. Société française d'anesthésie et de réanimation (Sfar), Collège national des gynécologues et obstétriciens français (CNGOF), Société française de médecine périnatale (SFMP) and Société française de néonatalogie (SFNN).
13. Berkow R, Beers MH, Fletscher AJ. Merck Manual Medisch handboek 2000, Bohn Stafleu Van Loghum, Houten/Diegem.
14. Williams J, Mozurkewich E, Chilimgras J, van de Ven C. Critical care in obstetrics: pregnancy-specific conditions. Best Pract Res Clin Obstet Gynaecol 2008, 22:825-846. 10.1016/j.bpobgyn.2008.06.003, 18775679.
15. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, van den Berg PP, de Boer K, Burggraaf JM, Bloemenkamp KW, Drogtrop AP, Franx A, de Groot CJ, Huisjes AJ, Kwee A, van Loon AJ, Lub A, Papatsonis DN, van der Post JA, Roumen FJ, Scheepers HC, Willekes C, Mol BW, van Pampus MG. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009, 374:979-988. 10.1016/S0140-6736(09)60736-4, 19656558.
16. Sep S, Smits L, Prins M, Peeters L. Prediction tests for recurrent hypertensive disease in pregnancy, a systematic review. Hypertens Pregnancy 2010, 29:206-230. 10.3109/10641950902968668, 20102284.
17. Sep SJS, Smits LJM, Prins MH, Spaanderman MEA, Peeters LLH. Simple prepregnant prediction rule for recurrent early-onset hypertensive disease in pregnancy. Reprod Sci 2009, 16:80-87. 10.1177/1933719108324889, 19144890.
18. Zhang J, Troendle JF, Levine RJ. Risks of hypertensive disorders in the second pregnancy. Paediatr Perinat Epidemiol 2001, 15:226-231. 10.1046/j.1365-3016.2001.00347.x, 11489149.
19. Anonymus EuroQoL--a new facility for the measurement of health- related quality of life. The EuroQol Group. Health Policy 1990, 16:199-208. 10.1016/0168-8510(90)90421-9, 10109801, Anonymus.
20. Spielberger CD, Gorsuch RL, Lushene RE. STAI Manual for the State- trait Anxiety Inventory. 1970, Consulting Psychologists Press: Palo Alto, CA.
21. Erbaugy JK, Mock JE, Mondelson M, Ward CH. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-671.
22. Foa EB, Riggs DS, Rothbaum B. Reliability and validity of a brief instrument for assessing post traumatic stress disorder. JTS 1993, 6:459-473.
23. Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001, 20:IX-XIV.
24. van Houwelingen JC, Thorogood J. Construction, validation and updating of a prognostic model for kidney graft survival. Stat Med 1995, 14:1999-2008. 10.1002/sim.4780141806, 8677400.
25. van Houwelingen JC. Validation, calibration, revision and combination of prognostic survival models. Stat Med 2000, 19:3401-15. 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2, 11122504.
26. D'Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286:180-7. 10.1001/jama.286.2.180, 11448281.
27. Oostenbrink JB, Bouwmans CAM, Koopmanschap MA, Rutten FFH. Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. 2004, Amstelveen: College voor Zorgverzekeringen (CVZ).
28. Buxton MJ, Drummond MF, van Hout BA, Prince RL, Sheldon TA, Szucs T, Vray M. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997, 6:217-227. 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO;2-W, 9226140.
29. Brennan A, Akehurst R. Modelling in Health Economic Evaluation: What is its place? What is its value?. Pharmacoeconomics 2000, 17:445-459. 10.2165/00019053-200017050-00004, 10977387.
30. PRN/TNO De thuisbevalling in Nederland, 1995-2002. Rapportage over de jaren 2001-2002 van PRN/TNO. 2002, PRN/TNO., http://www.perinatreg.nl/uploads/153/99/Rapportage_Thuisbevalling_2001-2002.pdf
31. ZonMW projectenpoort - Cost-effectiveness of recurrence risk-guided care of pregnant women with preeclampsia in the previous pregnancy. , http://www.zonmw.nl/nl/system/zoekresultaten/delfi/projecten-database/project-detail/?tx_videlfiprojecten_pi1%5Bproject_id%5D=4600267139